Results:
The mean age of the patients participating in the study was 30.8 ± 6.05
years. The mean baseline total sperm count was 53.86 million in the
Proxeed group and 49.82 million in the Carniact group, with no
significant difference between the groups (p> 0.05).
However, there was a statistically significant difference between the
two groups in terms of the pre-treatment baseline sperm motility and
morphology parameters (p<0.05) (Table 2). There was a
significant difference between the baseline and sixth-month total sperm
counts of the patients in each of the two groups (p<0.05)
(Table 3 and 4). However, no significant changes were found in total
semen volume in the Proxeed group and non-progressive motility in the
Carniact group after treatment (p> 0.05). There was also no
statistically significant difference between the two groups in terms of
post-treatment parameters (p>0.05) (Table 5).
Table 2 : Comparision groups before treatment